> 0 1 0 1 O
29.99 1 6 1 6 B-lower_bound
years 7 12 7 12 I-lower_bound
of 13 15 13 15 O
age 16 19 16 19 B-age

Age 0 3 20 23 B-age
≤1 4 6 24 26 O
year 7 11 27 31 I-upper_bound

Direct 0 6 32 38 O
bilirubin 7 16 39 48 B-clinical_variable
< 17 18 49 50 O
1.5 19 22 51 54 B-upper_bound
upper 23 28 55 60 I-upper_bound
limit 29 34 61 66 I-upper_bound
of 35 37 67 69 I-upper_bound
normal 38 44 70 76 I-upper_bound
( 45 46 77 78 I-upper_bound
ULN 46 49 78 81 I-upper_bound
) 49 50 81 82 I-upper_bound
for 51 54 83 86 O
age 55 58 87 90 O
, 58 59 90 91 O
and 60 63 92 95 O
SGOT 64 68 96 100 B-clinical_variable
( 69 70 101 102 I-clinical_variable
AST 70 73 102 105 I-clinical_variable
) 73 74 105 106 I-clinical_variable
or 75 77 107 109 O
SGPT 78 82 110 114 B-clinical_variable
( 83 84 115 116 I-clinical_variable
ALT 84 87 116 119 I-clinical_variable
) 87 88 119 120 I-clinical_variable
<3 89 91 121 123 O
x 92 93 124 125 I-upper_bound
ULN 94 97 126 129 I-upper_bound

Ejection 0 8 130 138 B-clinical_variable
fraction 9 17 139 147 I-clinical_variable
of 18 20 148 150 O
> 21 22 151 152 O
50 22 24 152 154 B-lower_bound
% 24 25 154 155 I-lower_bound
by 26 28 156 158 O
radionuclide 29 41 159 171 B-treatment
angiogram 42 51 172 181 I-treatment
or 52 54 182 184 O
echocardiogram 55 69 185 199 B-treatment

Females 0 7 200 207 B-gender
who 8 11 208 211 O
are 12 15 212 215 O
pregnant 16 24 216 224 B-pregnancy
( 25 26 225 226 O
positive 26 34 226 234 O
HCG 35 38 235 238 B-treatment
) 38 39 238 239 O

No 0 2 240 242 O
prior 3 8 243 248 B-treatment
Hodgkin 9 16 249 256 I-treatment
lymphoma 17 25 257 265 I-treatment
directed 26 34 266 274 I-treatment
therapy 35 42 275 282 I-treatment
is 43 45 283 285 O
allowed 46 53 286 293 O
except 54 60 294 300 O
for 61 64 301 304 O
emergent 65 73 305 313 O
mediastinal 74 85 314 325 B-treatment
irradiation 86 97 326 337 I-treatment
( 98 99 338 339 O
< 99 100 339 340 O
1000cGy 100 107 340 347 B-upper_bound
) 107 108 347 348 O
for 109 112 349 352 O
superior 113 121 353 361 B-cancer
vena 122 126 362 366 I-cancer
cava 127 131 367 371 I-cancer
( 132 133 372 373 I-cancer
SVC 133 136 373 376 I-cancer
) 136 137 376 377 I-cancer
syndrome 138 146 378 386 I-cancer

Normal 0 6 387 393 B-clinical_variable
Serum 7 12 394 399 I-clinical_variable
creatinine 13 23 400 410 I-clinical_variable
based 24 29 411 416 O
on 30 32 417 419 O
age 33 36 420 423 B-age
or 37 39 424 426 O
creatinine 40 50 427 437 B-age
clearance 51 60 438 447 I-age
> 61 62 448 449 O
60 62 64 449 451 B-lower_bound
ml 65 67 452 454 I-lower_bound
/ 67 68 454 455 I-lower_bound
min/1.73 68 76 455 463 I-lower_bound
m2 77 79 464 466 I-lower_bound

Shortening 0 10 467 477 B-clinical_variable
fraction 11 19 478 486 I-clinical_variable
> 20 21 487 488 O
27 21 23 488 490 B-lower_bound
% 23 24 490 491 I-lower_bound
by 25 27 492 494 O
echocardiogram 28 42 495 509 O

equivalent 0 10 510 520 O
radioisotope 11 23 521 533 O
glomerular 24 34 534 544 B-clinical_variable
filtration 35 45 545 555 I-clinical_variable
rate 46 50 556 560 I-clinical_variable
( 51 52 561 562 I-clinical_variable
GFR 52 55 562 565 I-clinical_variable
) 55 56 565 566 I-clinical_variable
as 57 59 567 569 O
determined 60 70 570 580 O
by 71 73 581 583 O
the 74 77 584 587 O
institutional 78 91 588 601 O
normal 92 98 602 608 O
range 99 104 609 614 O

patients 0 8 615 623 O
> 9 10 624 625 O
16 11 13 626 628 B-lower_bound
years 14 19 629 634 I-lower_bound
, 19 20 634 635 O
Karnofsky 21 30 636 645 B-clinical_variable
score 31 36 646 651 I-clinical_variable
of 37 39 652 654 O
≥60 40 43 655 658 O

patients 0 8 659 667 O
age 9 12 668 671 B-age
1 13 14 672 673 B-lower_bound
- 14 15 673 674 O
16 15 17 674 676 B-upper_bound
years 18 23 677 682 I-upper_bound
, 23 24 682 683 O
Lansky 25 31 684 690 B-clinical_variable
score 32 37 691 696 I-clinical_variable
of 38 40 697 699 O
≥60 41 44 700 703 O

